YERLİKAYA, A. Et Al. 2010. Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16FIO melanoma cell line. MOLECULAR MEDICINE REPORTS , vol.3, no.2 , 333-339.

YERLİKAYA, A., OKUR, E., Seker, S., & ERİN, N., (2010). Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16FIO melanoma cell line. MOLECULAR MEDICINE REPORTS , vol.3, no.2, 333-339.

YERLİKAYA, AZMİ Et Al. "Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16FIO melanoma cell line," MOLECULAR MEDICINE REPORTS , vol.3, no.2, 333-339, 2010

YERLİKAYA, AZMİ Et Al. "Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16FIO melanoma cell line." MOLECULAR MEDICINE REPORTS , vol.3, no.2, pp.333-339, 2010

YERLİKAYA, A. Et Al. (2010) . "Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16FIO melanoma cell line." MOLECULAR MEDICINE REPORTS , vol.3, no.2, pp.333-339.

@article{article, author={AZMİ YERLİKAYA Et Al. }, title={Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16FIO melanoma cell line}, journal={MOLECULAR MEDICINE REPORTS}, year=2010, pages={333-339} }